Cardiologs co-founder and CEO Yann Fleureau was named the European Innovator of the Year by MIT Technology Review. The company offers a cloud-based artificial intelligence (AI) platform that enables the detection of 14 cardiac arrhythmias through ambulatory electrocardiogram (ECG) readings.
A hospital’s suggestion that a Michigan woman raise $10,000 before being considered for a heart transplant fueled outrage last month, but that situation isn’t all that uncommon, according to a Dec. 5 story from Kaiser Health News.
A little weight lifting can have a big impact on heart health, even in the absence of aerobic endurance training, according to recent research in Medicine & Science in Sports & Exercise.
Showing patients and their primary care doctors pictorial representations of carotid plaque may prompt greater adherence to lifestyle and medication interventions, resulting in lower cardiovascular disease risk within one year, according to a study published Dec. 3 in The Lancet.
The authors of a new study in the Annals of Internal Medicine believe too many patients are being recommended statin therapy, and contend that current guidelines don’t fully consider the risks of the popular drugs.
Home telemonitoring approaches for heart failure patients are associated with lower odds of death at six months but not beyond that, according to a meta-analysis published in the December issue of Health Affairs.
It takes emergency medical services (EMS) almost four minutes longer to transport cardiac arrest patients from poor neighborhoods to the hospital versus those from high-income neighborhoods, according to a study of 2014 United States EMS data published in JAMA Network Open.
Seniors taking five or more prescription drugs to treat heart failure could be at an increased risk for functional impairment, according to a study published in the Journal of the American Geriatrics Society.
BTG plc (LSE: BTG), the global healthcare company, today announced the first patients outside of a clinical trial have been successfully implanted with the BTG Sentry device – the world’s first bioconvertible IVC filter.
Using a biomarker target to guide the treatment of patients with heart failure with reduced ejection fraction (HFrEF) resulted in higher healthcare costs without significant improvements in quality of life compared to standard treatment, according to an analysis from the GUIDE-IT study.
